(Q35832326)

English

Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1

scientific article published in February 1993

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1 (English)

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

monoclonal antibody

1 reference

based on heuristic

inferred from title

3

object named as

Olsson H

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

author name string

Kreipe H

1

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Alm P

2

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Hauberg M

4

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Fischer L

5

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Parwaresch R

6

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

language of work or name

0 references

publication date

1 February 1993

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

The American Journal of Pathology

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

142

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

651-657

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Cell kinetics as a prognostic marker in node-negative breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Interobserver reproducibility of histopathological features in stage II breast cancer. An ECOG study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Growth fractions and estrogen receptors in human breast cancers as determined in situ with monoclonal antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

New approach to assessing lung tumours in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Biological grading of breast cancer using antibodies to proliferating cells and other markers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Cytophotometric estimation of cell proliferation in breast cancer. Correlation to the clinical course during long-term follow-up.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Ki67 immunostaining in primary breast cancer: pathological and clinical associations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Ploidy analysis and S-phase fraction determination by flow cytometry of invasive adenocarcinomas of the breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Prognosis and breast cancer. Recognition of lethal and favorable prognostic types

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of tumor cell kinetics by immunohistochemistry in carcinoma of breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant therapy of node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of cytosolic estrogen and progesterone receptor content and the growth fraction in human mammary carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of hormone receptors in breast carcinoma by immunocytochemistry and image analysis. II. Estrogen receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indicators of prognosis in node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ki-67 immunostaining in human breast tumors and its relationship to prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

KiS1--a novel monoclonal antibody which recognizes proliferating cells: evaluation of its relationship to prognosis in mammary carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of early course of breast carcinoma by thymidine labeling

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The correlation of growth fractions with histologic grading and lymph node status in human mammary carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Proliferation marker Ki-67: correlation with histological diagnosis, neoplasm grading and clinical course]

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitation and estimation of lymphocyte subsets in tissue sections. Comparison with flow cytometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35832326&oldid=1647864698"